BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

543828

SUDARSHAN

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SUDARSHAN PHARMA INDUSTRIES LI Share Price Update

As of the latest trading session, SUDARSHAN PHARMA INDUSTRIES LI share price is currently at ₹ 27.2, which is down by ₹ -0.54 from its previous closing. Today, the stock has fluctuated between ₹ 27.20 and ₹ 27.20. Over the past year, SUDARSHAN PHARMA INDUSTRIES LI has achieved a return of 256.02 %. In the last month alone, the return has been -12.68 %. Read More...

SUDARSHAN PHARMA INDUSTRIES LI fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    65.45

  • P/E Ratio (TTM)

    41.21

  • Beta

    0.50

  • Book Value / share

    5.29

  • Return on equity

    10.69%

  • EPS (TTM)

    0.75

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

SUDARSHAN PHARMA INDUSTRIES LI Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 502.51
Operating Expense 481.28
Net Profit 15.88
Net Profit Margin (%) 3.16
Earnings Per Share (EPS) 0.66
EBITDA 38.56
Effective Tax Rate (%) 25.41
Particulars MAR 2024 (Values in Cr)
Revenue 465.56
Operating Expense 453.21
Net Profit 11.36
Net Profit Margin (%) 2.44
Earnings Per Share (EPS) 4.72
EBITDA 25.36
Effective Tax Rate (%) 24.76
Particulars MAR 2023 (Values in Cr)
Revenue 461.33
Operating Expense 452.95
Net Profit 7.04
Net Profit Margin (%) 1.52
Earnings Per Share (EPS) 5.46
EBITDA 15.81
Effective Tax Rate (%) 25.89
Particulars MAR 2022 (Values in Cr)
Revenue 357.09
Operating Expense 350.42
Net Profit 5.25
Net Profit Margin (%) 1.47
Earnings Per Share (EPS) 5.46
EBITDA 11.38
Effective Tax Rate (%) 26.47
Particulars MAR 2021 (Values in Cr)
Revenue 193.35
Operating Expense 190.04
Net Profit 2.67
Net Profit Margin (%) 1.38
Earnings Per Share (EPS) 2.80
EBITDA 7.45
Effective Tax Rate (%) 25.13
Particulars MAR 2024 (Values in Cr)
Book Value / Share 46.42
ROE % 10.78
ROCE % 13.74
Total Debt to Total Equity 0.65
EBITDA Margin 5.48
Particulars MAR 2023 (Values in Cr)
Book Value / Share 41.96
ROE % 10.77
ROCE % 15.24
Total Debt to Total Equity 0.49
EBITDA Margin 3.42
Particulars MAR 2022 (Values in Cr)
Book Value / Share 30.54
ROE % 20.08
ROCE % 18.67
Total Debt to Total Equity 1.15
EBITDA Margin 3.19
Particulars MAR 2021 (Values in Cr)
Book Value / Share 23.58
ROE % 12.61
ROCE % 14.63
Total Debt to Total Equity 1.19
EBITDA Margin 3.90
Particulars MAR 2020 (Values in Cr)
Book Value / Share 20.78
ROE % 6.45
ROCE % 10.92
Total Debt to Total Equity 1.05
EBITDA Margin 3.23
Particulars MAR 2024 (Values in Cr)
Book Value / Share 46.38
ROE % 10.69
ROCE % 13.64
Total Debt to Total Equity 0.66
EBITDA Margin 5.45
Particulars MAR 2023 (Values in Cr)
Book Value / Share 41.96
ROE % 10.77
ROCE % 15.24
Total Debt to Total Equity 0.49
EBITDA Margin 3.43
Particulars MAR 2022 (Values in Cr)
Book Value / Share 30.55
ROE % 20.08
ROCE % 18.67
Total Debt to Total Equity 1.15
EBITDA Margin 3.19
Particulars MAR 2021 (Values in Cr)
Book Value / Share 23.58
ROE % 12.61
ROCE % 14.63
Total Debt to Total Equity 1.19
EBITDA Margin 3.90
Particulars MAR 2020 (Values in Cr)
Book Value / Share 20.78
ROE % 6.63
ROCE % 12.01
Total Debt to Total Equity 0.91
EBITDA Margin 3.23
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 283.12
Total Liabilities 283.12
Total Equity 111.70
Share Outstanding 24065887
Price to Book Ratio 1.60
Return on Assets (%) 4.04
Return on Capital (%) 5.29
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 11.71
Total Assets 232.47
Total Liabilities 232.47
Total Equity 100.97
Share Outstanding 24065887
Price to Book Ratio 1.33
Return on Assets (%) 3.02
Return on Capital (%) 5.21
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.23
Total Assets 137.52
Total Liabilities 137.52
Total Equity 29.77
Share Outstanding 9748998
Price to Book Ratio 0.00
Return on Assets (%) 3.81
Return on Capital (%) 8.69
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.25
Total Assets 99.26
Total Liabilities 99.26
Total Equity 22.55
Share Outstanding 9748998
Price to Book Ratio 0.00
Return on Assets (%) 2.69
Return on Capital (%) 5.42
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 284.84
Total Liabilities 284.84
Total Equity 111.61
Share Outstanding 24065887
Price to Book Ratio 1.60
Return on Assets (%) 3.98
Return on Capital (%) 5.2
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 11.71
Total Assets 232.46
Total Liabilities 232.46
Total Equity 100.98
Share Outstanding 24065887
Price to Book Ratio 1.33
Return on Assets (%) 3.02
Return on Capital (%) 5.21
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.22
Total Assets 137.51
Total Liabilities 137.51
Total Equity 29.78
Share Outstanding 9748998
Price to Book Ratio 0.00
Return on Assets (%) 3.81
Return on Capital (%) 8.7
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.15
Total Assets 99.21
Total Liabilities 99.21
Total Equity 22.50
Share Outstanding 9546998
Price to Book Ratio 0.00
Return on Assets (%) 2.69
Return on Capital (%) 5.11
Particulars MAR 2024 (Values in Cr)
Net Income 15.22
Cash from Operations 8.16
Cash from Investing -5.49
Cash from Financing -12.09
Net change in Cash -11.57
Free Cash Flow 10.08
Particulars MAR 2023 (Values in Cr)
Net Income 9.49
Cash from Operations -26.68
Cash from Investing -25.65
Cash from Financing 65.92
Net change in Cash 11.48
Free Cash Flow -12.36
Particulars MAR 2022 (Values in Cr)
Net Income 7.13
Cash from Operations -2.05
Cash from Investing -1.45
Cash from Financing 4.26
Net change in Cash -1.01
Free Cash Flow -0.93
Particulars MAR 2021 (Values in Cr)
Net Income 3.57
Cash from Operations 3.60
Cash from Investing -1.29
Cash from Financing -1.48
Net change in Cash -0.01
Free Cash Flow 4.92
Particulars MAR 2020 (Values in Cr)
Net Income 1.71
Cash from Operations 0.97
Cash from Investing -2.38
Cash from Financing -0.27
Net change in Cash -2.14
Free Cash Flow 5.01
Particulars MAR 2024 (Values in Cr)
Net Income 15.09
Cash from Operations 10.07
Cash from Investing -7.34
Cash from Financing -12.18
Net change in Cash -11.57
Free Cash Flow 11.98
Particulars MAR 2023 (Values in Cr)
Net Income 9.49
Cash from Operations -26.68
Cash from Investing -25.65
Cash from Financing 65.92
Net change in Cash 11.48
Free Cash Flow -12.35
Particulars MAR 2022 (Values in Cr)
Net Income 7.13
Cash from Operations -1.93
Cash from Investing -1.53
Cash from Financing 4.30
Net change in Cash -0.92
Free Cash Flow -0.81
Particulars MAR 2021 (Values in Cr)
Net Income 3.57
Cash from Operations 3.71
Cash from Investing -1.34
Cash from Financing -1.63
Net change in Cash -0.11
Free Cash Flow 5.03
Particulars MAR 2020 (Values in Cr)
Net Income 1.71
Cash from Operations 0.97
Cash from Investing -2.52
Cash from Financing -0.27
Net change in Cash -2.29
Free Cash Flow 5.01
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 781.95 47.48 6.65 27446.45 574.70 / 1035.70
KOTHARI INDUSTRIAL CORPORATION 281.95 50.62 18.66 2190.30 4.01 / 281.95
MYSORE PETRO CHEMICALS LTD. 124.95 6.38 0.36 82.26 117.45 / 261.90
OSWAL AGRO MILLS LTD 78.11 20.61 1.24 1048.47 41.50 / 108.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 781.95 63.94 10.95 27446.45 574.70 / 1035.70
UTIQUE ENTERPRISES LIMITED 4.61 18.44 0.34 25.67 3.77 / 10.88
COMPUTER POINT LTD. 5.11 0.00 0.45 15.33 4.24 / 11.63
KOTHARI INDUSTRIAL CORPORATION 281.95 50.62 18.67 2190.30 4.01 / 281.95

SUDARSHAN PHARMA INDUSTRIES LI Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
27.20 -1.98 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 27.70
  • 26 Days 29.60
  • 10 Days 28.20
  • 50 Days 31.60
  • 12 Days 28.40
  • 100 Days 33.40
  • 20 Days 29.10
  • 200 Days 30.70
27.75 PIVOT

First Support

27.75

First Resistance

27.75

Second Support

27.75

Second Resistance

27.75

Third Support

27.75

Third Resistance

27.75

RSI

35.07

ADX

16.95

MACD

-1.14

Williams % R

-94.65

Commodity Channel Index (CCI)

-120.34

Date

2025-04-30

Week

117333.00

Same Day

16000.00

Month

119778.00

1 Year

0.51

3 Year

0.55

Over 1 Month

-12.68%

down

Over 1 Year

256.02%

down

Over 3 Months

-36.44%

down

Over 3 Years

57.66%

down

Over 6 Months

-29.31%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

SUDARSHAN PHARMA INDUSTRIES LI shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
24.15%
Promoter Holdings
57.38%
FII
18.45%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Sachin Vasantrai Mehta 6.620547E7 (27.51%) Shareholding of Promoter and Promoter Group
Hemal Vasantrai Mehta 6.402102E7 (26.6%) Shareholding of Promoter and Promoter Group
Multitude Growth Funds Limited 1.3276E7 (5.52%) Public Shareholding
Coeus Global Opportunities Fund 8864000.0 (3.68%) Public Shareholding
Century India Opportunity Fund Pc 5760000.0 (2.39%) Public Shareholding
Radiant Global Fund - Class B Participating Shares 5120000.0 (2.13%) Public Shareholding
Eminence Global Fund Pcc - Eubilia Capital Partners 4396000.0 (1.83%) Public Shareholding
Nexpact Limited 3228000.0 (1.34%) Public Shareholding
Bishwanath Prasad Agrawal 2568000.0 (1.07%) Public Shareholding
Devangi Hemal Mehta 2294070.0 (0.95%) Shareholding of Promoter and Promoter Group
Namrata Sachin Mehta 1645120.0 (0.68%) Shareholding of Promoter and Promoter Group
Sachin V Mehta Huf 1645120.0 (0.68%) Shareholding of Promoter and Promoter Group
Hemal V Mehta Huf 1645120.0 (0.68%) Shareholding of Promoter and Promoter Group
Vasantray Ratilal Mehta 493190.0 (0.2%) Shareholding of Promoter and Promoter Group
Jatin Vasantrai Mehta 164470.0 (0.07%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

SUDARSHAN PHARMA INDUSTRIES LI corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
25 Aug 2023 0.3 Final 26 Aug 2023 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

SUDARSHAN PHARMA INDUSTRIES LI Share Price

Sudarshan Pharma Industries Limited was originally incorporated as a Private Limited Company with the name 'Sudarshan Specialty Chemsolve Private Limited' on July 23, 2008 with the Registrar of Companies, Mumbai. Later in the year 2016. name of the Company was changed from 'Sudarshan Specialty Chemsolve Private Limited' to 'Sudarshan Pharma Industries Private Limited' on 17 December 2016. Thereafter, the Company converted into a Public Limited pursuant to a special resolution passed by shareholders at the EGM held on December 12, 2016 and consequently, name of the Company was changed to 'Sudarshan Pharma Industries Limited' on January 5, 2017.

The Company was promoted by Mr. Hemal V. Mehta & Mr. Sachin V. Mehta, who have a combined experience of over 25 years in the Special Chemical, Bulk drug and Pharmaceutical Industry. At present, Company is into Specialty Chemicals & Intermediates for Pharma, agro chemicals, Coating, various other industries. We are also into Active Pharmaceuticals Ingredients manufacturing. Our main focus is on Vitamin and API. The Company has setup its Unit at Palghar, Maharashtra. Key activities at this unit includes testing of raw materials to dispensing raw materials for formulations, to batch manufacturing as per approved standards, to packing of finished formulations, to storage and dispatch. Maharashtra Government policies and subsidies for new project is supportive and eases the initial financial burden required for setting up a large scale manufacturing unit.

The Company outsources its manufacturing facility, deal in Import and Exports, indenting and Supply in Specialty chemicals, API & its intermediate. As per the clients need and requirement, the company provides order and get them manufactured from various suppliers in India and abroad regularly. Specialty chemicals and Intermediates having wide application in pharma, paint, food and adhesive Industry. It is also involved in Contract Manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals. It also offer services of QC and Formulation Development to provide customised solutions to our customers and assist them in sourcing the innovative products as per their needs.

The Company carries about Ethical marketing of Pharmaceutical formulation & products in the Domestic and International market through distribution network and Sales force under its own brand. Presently, the Company has joined hands with regular suppliers having FDA and WHO approved plant along with their own unit to supply pharma formulation and more than 100 generic pharma products. These units manufacture tablets, capsules, dry powder, dry injections powder, liquids, Injections & dry injections for their own brands.

Apart from these, the Company has launched wide products range in pharma formulation such as Setdown, Pulmo relief, Fix Pollen, Flupimac and has established goodwill for quality products and have regular clients for the same. Further, it supplies generic pharmaceutical formulation as Make to order for bulk supply to the hospital, Health Centre of Corporate, Municipality and exports.

The Company operate both in domestic and international markets. Presently, it is supplying Active Pharmaceutical Ingredients
(APIs), Intermediates Finished Dosage Formulations (FDFs) and Specialty Chemicals (SCs) in the domestic markets. It has entered into MOU / Agreements with Storage Houses / Warehouses facility providers at Bhiwandi Thane, Maharashtra, Wada Palghar, Maharashtra and Baddi, Himachal Pradesh for using their premises for the stock keeping of the products. The Company has also entered into Lease Agreement with Group Company, Sudarshan Chempharm LLP for using its premises and land to set up proposed Manufacturing and Storage / Warehouse Facility at Wada, in Maharashtra.

In domestic pharmaceuticals markets, currently, the Company has good presence and is servicing through a Supply Chain Network of Consignee Agents with products range. It also provide onsite support & assistance to clients using their Drug Intermediates and Specialty Chemicals.

The Company made an Initial Public Offer by issuing 68,62,400 Equity Shares of face value of Rs 10 each by raising funds aggregating to Rs. 50 Crore, through Fresh Issue in March, 2023.

Ratna Lifesciences Private Limited was incorporated as a wholly owned subsidiary company on November 10, 2023. The Company achieved development of the molecule VITAMIN B6 (Pyridoxine Hydrochloride) from base root till the finished product and also manufactured all the intermediary products required to manufacture the finished API products of 'VITAMIN B6'. It also achieved first milestone in developing the sample for the molecule VITAMIN B1 (Thiamine Hydrochloride) from Base Root for Manufacturing Process of 'VITAMIN B1'. Life Science Chemical was incorporated on August 23, 2023.

Parent organization Indian Private
NSE symbol [-]
Founded 2008
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Sudarshan Pharma Industries Ltd?

Answer Field

The share price of Sudarshan Pharma Industries Ltd for NSE is ₹ 0.00 and for BSE is ₹ 27.20.

What is the Market Cap of Sudarshan Pharma Industries Ltd?

Answer Field

The market cap of Sudarshan Pharma Industries Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 6,54.60 Cr. as of now.

What is the 52 Week High and Low of Sudarshan Pharma Industries Ltd?

Answer Field

The 52 Week High and Low of Sudarshan Pharma Industries Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 53.50 and ₹ 5.82.

How to Buy Sudarshan Pharma Industries Ltd share?

Answer Field

You can trade in Sudarshan Pharma Industries Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sudarshan Pharma Industries Ltd?

Answer Field

The 1 year returns on the stock has been 248.61%.

What is the Current Share Price of Sudarshan Pharma Industries Ltd?

Answer Field

Sudarshan Pharma Industries Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 27.20 as on Apr 30 2025 12:15 PM.

What is the Market Cap of Sudarshan Pharma Industries Ltd Share?

Answer Field

The market cap of Sudarshan Pharma Industries Ltd for NSE ₹ 0.0 & for BSE ₹ 6,54.60 as on Apr 30 2025 12:15 PM.

What is the P/E Ratio of Sudarshan Pharma Industries Ltd Share?

Answer Field

As on Apr 30 2025 12:15 PM the price-to-earnings (PE) ratio for Sudarshan Pharma Industries Ltd share is 41.21.

What is the PB ratio of Sudarshan Pharma Industries Ltd Share?

Answer Field

As on Apr 30 2025 12:15 PM, the price-to-book (PB) ratio for Sudarshan Pharma Industries Ltd share is 5.29.

How to Buy Sudarshan Pharma Industries Ltd Share?

Answer Field

You can trade in Sudarshan Pharma Industries Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sudarshan Pharma Industries Ltd Share on Bajaj Broking App?

Answer Field

To buy Sudarshan Pharma Industries Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sudarshan Pharma Industries Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|